Medications Updated During February 2020, From Newest to Oldest

Page 1 of 71 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Alprostadil

Alprostadil injection USP is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be…

Teva Parenteral Medicines, Inc.29 February 2020

Irinotecan Hydrochloride

Irinotecan Hydrochloride Injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based…

Actavis Pharma, Inc.29 February 2020

Dacarbazine

Dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. In addition. Dacarbazine for injection is also indicated for Hodgkin’s disease as a…

Teva Parenteral Medicines, Inc.29 February 2020

Propofol

Propofol Injectable Emulsion is an IV general anesthetic and sedation drug that can be used as described in the table below. Table 3. Indications for Propofol Injectable Emulsion…

Actavis Pharma, Inc.29 February 2020

Clonidine Hydrochloride

Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant…

Actavis Pharma, Inc.29 February 2020

Page 1 of 71 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping
Wed, 01 Dec 2021. Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature…
August 7, 2019 UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality
Wed, 01 Dec 2021. The FDA is providing updated information about a late mortality signal in patients treated for peripheral artery disease (PAD) in the femoropopliteal artery with paclitaxel-coated balloons and paclitaxel-eluting stents. This communication updates…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.